Deckie Pharmaceuticals-B (06996.HK) plans to repurchase up to 40 million Hong Kong dollars of shares.

Zhtng Cijng APP News, Deqi Pharmaceuticals-B (06996.HK) announced that on August 29, 2025, the board of directors has approved a resolution to exercise its power under the share repurchase authorization to repurchase shares in the open market at a maximum total price of 40 million Hong Kong dollars. The repurchased shares will be subsequently cancelled or held by the company as treasury shares.